Improved personalised cancer treatment using single patient tissue
In order to achieve the vision of personalised cancer treatment, clinical pathology must develop better tools to be able to “predict in the tissue”, i.e., identify biological properties, known as biomarkers, in individual tumours, which are of significance to disease progression (prognosis) and the effect of different treatments (prediction). The